raises

Pharmacies compounding Semaglutide raises concerns

by
Pharmacies compounding Semaglutide raises concerns

The US Food and Drug Administration (FDA) recently warned two online suppliers to stop manufacturing unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes). 2; Wegovy for obesity) and tirzepatide (Mounjaro). With ongoing shortages of these two popular drugs, compounded versions have become popular. According to the FDA, compounding pharmacies are allowed to … Read more

New Alzheimer’s drug raises hopes along with questions

by
New Alzheimer's drug raises hopes along with questions

The FDA has approved Leqembi, the first disease treatment for early-stage Alzheimer’s disease and its precursor condition mild cognitive impairment. Medicare said it would pay for the treatment. Medical centers across the country are working to finalize policies and procedures for providing medications to patients, possibly by late summer or early fall. It’s a challenging … Read more